FindTrial
Sign In

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression. - A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047959
Enrollment
3677
Registered
2022-06-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Sponsors

Japanese Foundation for Multidisciplinary Treatment of Cancer
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Of the 4 studies (No.7, 15, 35, 38)conducted by JFMC in the past, registered cases diagnosed with rectal cancer were included in the analysis.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Relapse-free survival—

Secondary

MeasureTime frame
Overall survival—

Countries

Japan

Contacts

Public ContactYukari/Masaru Kawamura/Mutoh

Japanese Foundation for Multidisciplinary Treatment of Cancer Data Management Section/Statistical Analysis Section

jfmc-dc@jfmc.or.jp0356277594

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026